Friday, April 26, 9:00 – 10:30 am
Rooms C.L.E.M.
Chairs: Thomas L. Carroll (USA) – Nikki Johnston (USA)
- When should you use PPIs for LPR and when should you not? – Serhat Bor (Turkey)
- What is the rate of pepsin saliva positivity in asymptomatic individuals and does multi-sampling help us choose treatment? – Jacqueline Allen (New Zealand)
- How do anti-pepsin therapies protect against reflux-mediated damage? – Simon Blaine-Sauer (USA)
- What is the aetiologic evidence for reflux in adult and pediatric subglottic stenosis? – Derrick R. Randall (Canada)
- What are the interactions between laryngopharyngeal reflux and chronic cough? – Jonathan Bock (USA)
- How do we determine when the cause of an LPR symptom is due to other laryngeal pathology? – Thomas L. Carroll (USA)
- What has been learned about GERD from the lung transplant world? – Sumeet Mittal (USA)